[
  {
    "ts": "2025-10-31T19:21:31+00:00",
    "headline": "Why Bio-Techne (TECH) Stock Is Up Today",
    "summary": "Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment firm raised its price target on Bio-Techne to $62 from $53. The stock's rise also occurred as the broader market showed strength. Stocks rose after solid earnings reports from major tech companies like Apple and Amazon beat expectations, which seemed to spark a rally in the sector. Bio-Techne's move f",
    "url": "https://finance.yahoo.com/news/why-bio-techne-tech-stock-192131516.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "af27d479-367b-37b7-bc4a-34086eba5ab5",
      "content": {
        "id": "af27d479-367b-37b7-bc4a-34086eba5ab5",
        "contentType": "STORY",
        "title": "Why Bio-Techne (TECH) Stock Is Up Today",
        "description": "",
        "summary": "Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment firm raised its price target on Bio-Techne to $62 from $53. The stock's rise also occurred as the broader market showed strength. Stocks rose after solid earnings reports from major tech companies like Apple and Amazon beat expectations, which seemed to spark a rally in the sector. Bio-Techne's move f",
        "pubDate": "2025-10-31T19:21:31Z",
        "displayTime": "2025-10-31T19:21:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "TECH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LYiy8pdxjjKKPO37OJyQAg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D4gEv3cExkoBPyh482djbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-bio-techne-tech-stock-192131516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-bio-techne-tech-stock-192131516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]